Page last updated: 2024-10-30

mepivacaine and Parkinson Disease

mepivacaine has been researched along with Parkinson Disease in 1 studies

Mepivacaine: A local anesthetic that is chemically related to BUPIVACAINE but pharmacologically related to LIDOCAINE. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From AMA Drug Evaluations, 1994, p168)
mepivacaine : A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nord, M1
Zsigmond, P1
Kullman, A1
Arstrand, K1
Dizdar, N1

Other Studies

1 other study available for mepivacaine and Parkinson Disease

ArticleYear
The effect of peripheral enzyme inhibitors on levodopa concentrations in blood and CSF.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Feb-15, Volume: 25, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antiparkinson Agents; Area Under Curve; Catechols; Do

2010